1.020GBp0.00%Mkt Cap: 23.93M GBpP/E: —Last update: 2026-05-13
Provexis plc, together with its subsidiaries, develops, licenses, and sells functional foods, medical foods, and dietary supplements worldwide. The company offers syrup and powder versions of Fruitflow, a tomato extract …
Industry Peers
Drug Manufacturers - Specialty & Genericloading…
Indicators:|
Key Statistics
Valuation
P/E (Trailing)—
P/E (Forward)—
PEG—
P/B—
P/S26.93
EV/EBITDA—
EV/Revenue25.71
EPS (TTM)0.00
EPS (Forward)—
Cash Flow & Leverage
FCF Yield-1.36%
FCF Margin-37.23%
Operating CF-340.83K GBp
CapEx (TTM)—
Net Debt/EBITDA—
Net Debt-523.35K GBp
Technical
SMA 501.039 (-1.8%)
SMA 2000.8361 (+22.0%)
Beta0.66
S&P 52W Chg24.23%
Avg Vol (30d)1.78M
Avg Vol (10d)419.49K
Technical Indicators
RSI (14)47.9
MACD-0.0136
MACD Signal-0.0195
MACD Hist.+0.0059
BB Upper1.069 GBp
BB Middle1.021 GBp
BB Lower0.9726 GBp
BB Width9.48%
ATR (14)0.1715 GBp
Vol Ratio (20d)0.98x
52W Range
0.006266% of range1.550
52W High1.550 GBp
52W Low0.0062 GBp
Profitability
Gross Margin41.24%
EBITDA Margin0.00%
Profit Margin-35.03%
Oper. Margin-85.00%
ROE-34.89%
ROA-44.73%
Revenue Growth-53.60%
Earnings Growth—
Balance Sheet
Debt/Equity—
Current Ratio3.65
Quick Ratio3.46
Book Value/Sh0.0000 GBp
Cash/Share0.0000 GBp
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 GBp
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Splits
Last Split2:1
Split DateJun 23, 2005
Ownership
Shares Out.2.35B
Float1.78B
Insiders20.03%
Institutions10.06%
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Company
Market Cap23.93M GBp
Enterprise Value22.40M GBp
Revenue (TTM)871.26K GBp
Gross Profit532.94K GBp
Net Income (TTM)-452.72K GBp
Revenue/Share0.0000 GBp
Fiscal Year EndMar 2025
MR QuarterSep 2025
Employees2
Last Price1.020 GBp
CountryGB
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
ISIN—